Pancrease

Background: Pancreatic enzyme replacement therapy (PERT) improves nutritional status and growth in patients with cystic fibrosis… Expand

BACKGROUND Primary Sjögren's syndrome (pSS) is one of the autoimmune diseases with high incidence. There were several clinical… Expand

Pancreatic function tests were performed in 11 adult cystic fibrosis (CF) patients with a fecal fat excretion of more than 10… Expand

Choosing the optimum pancreatic enzyme replacement therapy for patients with exocrine insufficiency remains a problem. An enteric… Expand

Objectives: Enteric‐coated microsphere/microtablet pancreatin should stay intact in the stomach and dissolve promptly on entering… Expand

We studied the effect of the addition of omeprazole (20 mg once a day) to treatment with pancreatin (Pancrease, Cilag, Herentals… Expand

Pancreatic enzyme products are formulated, manufactured, and sold without submitting efficacy or bioavailability data to the Food… Expand

In order to avoid inactivation in the stomach, pancreatic enzymes have been prepared as pH-sensitive, enteric-coated microspheres… Expand

Four different pancreatin products, Pancrease, Creon, Pancrex V Forte, and Pancreatin Merck, were compared in a random crossover… Expand

ABSTRACT. Pancreatic extracts, even in high doses, usually fail to completely control steatorrhoea in cystic fibrosis (CF), due… Expand